Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab

dc.contributor.author	GÜL, Ahmet
dc.contributor.author	Toz, Bahtiyar
dc.contributor.author	İNANÇ, Murat
dc.contributor.author	ŞENTÜRK, Nihan
dc.contributor.author	Erer, Burak
dc.contributor.author	Kamali, Sevil
dc.contributor.author	Ocal, Lale
dc.date.accessioned	2022-02-18T10:51:35Z
dc.date.available	2022-02-18T10:51:35Z
dc.identifier.citation	Toz B., İNANÇ M., Erer B., ŞENTÜRK N., Kamali S., Ocal L., GÜL A., "Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab", ARTHRITIS & RHEUMATOLOGY, cilt.67, 2015
dc.identifier.issn	2326-5191
dc.identifier.other	vv_1032021
dc.identifier.other	av_c15ce240-d9d5-4713-a73c-109b9e97b581
dc.identifier.uri	http://hdl.handle.net/20.500.12627/180031
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	İmmünoloji ve Romatoloji
dc.subject	Rheumatology
dc.subject	Health Sciences
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	ROMATOLOJİ
dc.title	Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab
dc.type	Makale
dc.relation.journal	ARTHRITIS & RHEUMATOLOGY
dc.contributor.department	, ,
dc.identifier.volume	67
dc.contributor.firstauthorID	3146766

Files in this item

Files	Size	Format	View
There are no files associated with this item.